These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 23929449)

  • 1. International Journal of Toxicology special edition volume of MMB4 DMS.
    Burback BL; Cabell LA; Johnson JD; McDonough JA; Osheroff MR
    Int J Toxicol; 2013; 32(4 Suppl):3S-4S. PubMed ID: 23929449
    [No Abstract]   [Full Text] [Related]  

  • 2. Monitoring the pharmacokinetics of pyridinium aldoximes in the body.
    Kalász H; Furész J; Tekes K
    Mini Rev Med Chem; 2009 May; 9(5):596-610. PubMed ID: 19456290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and pharmacokinetic/pharmacodynamic study of 1,1'-methylenebis{4-[(hydroxyimino)methyl] pyridinium} dimethanesulfonate in guinea pigs and rhesus macaques exposed to cyclosarin.
    Harvilchuck JA; Hong SP; Richey JS; Osheroff MR; Johnson JD
    Int J Toxicol; 2013; 32(4 Suppl):108S-17S. PubMed ID: 23929444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absorption, distribution, metabolism, and excretion of 14C-MMB4 DMS administered intramuscularly to Sprague-Dawley rats and New Zealand White rabbits.
    Lusiak BD; Kobs DJ; Hong SP; Burback BL; Johnson JD
    Int J Toxicol; 2013; 32(4 Suppl):88S-98S. PubMed ID: 23929453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative toxicokinetics of MMB4 DMS in rats, rabbits, dogs, and monkeys following single and repeated intramuscular administration.
    Hong SP; Gibbs ST; Kobs DJ; Hawk MA; Croutch CR; Osheroff MR; Johnson JD; Burback BL
    Int J Toxicol; 2013; 32(4 Suppl):38S-48S. PubMed ID: 23929448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluations of in vitro metabolism, drug-drug interactions mediated by reversible and time-dependent inhibition of CYPs, and plasma protein binding of MMB4 DMS.
    Hong SP; Lusiak BD; Burback BL; Johnson JD
    Int J Toxicol; 2013; 32(4 Suppl):75S-87S. PubMed ID: 23929452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacology, Pharmacokinetics, and Tissue Disposition of Zwitterionic Hydroxyiminoacetamido Alkylamines as Reactivating Antidotes for Organophosphate Exposure.
    Sit RK; Kovarik Z; Maček Hrvat N; Žunec S; Green C; Fokin VV; Sharpless KB; Radić Z; Taylor P
    J Pharmacol Exp Ther; 2018 Nov; 367(2):363-372. PubMed ID: 30190337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MMB4 DMS nanoparticle suspension formulation with enhanced stability for the treatment of nerve agent intoxication.
    Dixon H; Clark AP; Cabell LA; McDonough JA
    Int J Toxicol; 2013; 32(4 Suppl):18S-29S. PubMed ID: 23929445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Good manufacturing practice: manufacturing of a nerve agent antidote nanoparticle suspension.
    Clark AP; Dixon H; Cantu NL; Cabell LA; McDonough JA
    Int J Toxicol; 2013; 32(4 Suppl):5S-17S. PubMed ID: 23929446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systems dynamics approach to the efficacy of oxime therapy for mild exposure to sarin gas.
    Droste DJ; Shelley ML; Gearhart JM; Kempisty DM
    Am J Disaster Med; 2016; 11(2):89-118. PubMed ID: 28102531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of MMB4 DMS in rats, rabbits, and dogs following a single IV administration.
    Hong SP; Gibbs ST; Kobs DJ; Osheroff MR; Johnson JD; Burback BL
    Int J Toxicol; 2013; 32(4 Suppl):30S-7S. PubMed ID: 23929447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reactivators of acetylcholinesterase inhibited by organophosphorus nerve agents.
    Mercey G; Verdelet T; Renou J; Kliachyna M; Baati R; Nachon F; Jean L; Renard PY
    Acc Chem Res; 2012 May; 45(5):756-66. PubMed ID: 22360473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacological tolerance to medical therapy of organophosphate poisoning and ways of tolerance management].
    Iudin MA; Bykov VN; Chepur SV; Sarana AM; Tsygan VN; Anokhin AG
    Voen Med Zh; 2014 May; 335(5):26-31. PubMed ID: 25286560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different approaches to acute organophosphorus poison treatment.
    Nurulain SM
    J Pak Med Assoc; 2012 Jul; 62(7):712-7. PubMed ID: 23866522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current understanding of the application of pyridinium oximes as cholinesterase reactivators in treatment of organophosphate poisoning.
    Jokanović M; Stojiljković MP
    Eur J Pharmacol; 2006 Dec; 553(1-3):10-7. PubMed ID: 17109842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pretreatment with pyridinium oximes improves antidotal therapy against tabun poisoning.
    Lucić Vrdoljak A; Calić M; Radić B; Berend S; Jun D; Kuca K; Kovarik Z
    Toxicology; 2006 Nov; 228(1):41-50. PubMed ID: 16982122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of novel oximes for treatment of poisoning by organophosphorus compounds.
    Worek F; Thiermann H
    Pharmacol Ther; 2013 Aug; 139(2):249-59. PubMed ID: 23603539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug development for the management of organophosphorus poisoning.
    Elsinghorst PW; Worek F; Thiermann H; Wille T
    Expert Opin Drug Discov; 2013 Dec; 8(12):1467-77. PubMed ID: 24125474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of Two Chlorine-Substituted Bis-Pyridinium Mono-Aldoximes with Regenerating Effect on Butyrylcholinesterase.
    Kalász H; Szimrók Z; Karvaly G; Adeghate J; Tekes K
    Molecules; 2020 Mar; 25(5):. PubMed ID: 32164301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain-targeting delivery of MMB4 DMS using carrier-free nanomedicine CRT-MMB4@MDZ.
    Du Y; Gao J; Zhang H; Meng X; Qiu D; Gao X; Zheng A
    Drug Deliv; 2021 Dec; 28(1):1822-1835. PubMed ID: 34515590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.